Abstract
In this study, experimental hypothyroidism was established and used to investigate possible alterations in the calcium, magnesium, and zinc homeostasis by assessing their concentration in plasma and erythrocytes. Hypothyroidism was induced by administration of methimazole an iodine blocker at a dose of 75 mg/100 g food for 3 wk.
In the methimazole-induced hypothyroid state, the experimental animals showed a significant decrease in plasma zinc concentration, whereas a significant increase in plasma magnesium concentration occurred. No change was observed in plasma calcium concentration. The erythrocyte zinc and calcium concentrations were found to be increased, whereas magnesium concentration decreased. Erythrocyte magnesium concentration showed a significant positive correlation with T4 values.
The study provides evidence for marked alterations in homeostatis of zinc, magnesium, and calcium.
Similar content being viewed by others
References
R. K. Rude, Magnesium metabolism and deficiency,Endocrinology Metab. Clin. North Am. 22, 377–395 (1993).
A. Prasad, Clinical manifestations of zinc deficiency,Ann Rev. Nutr. 5, 341–363, (1985).
K. D. Burman, J. M. Monchik, J. M. Earll, and L. Wartofsky, Ionized and total serum calcium and parathyroid hormone in hyperthyroidism,Ann Intern. Med. 84, 668–671 (1976).
E. Dolev, P. A. Deuster, B. Solomon, U. H. Trostmann, L. Wartofsky, and K. D. Burman, Alterations in magnesium and zinc metabolism in thyroid disease, Metabolism37, 61–67 (1988).
A. O. Olukoga, R T. Erasmus, and H. O. Adewaye, Erythrocyte and plasma magnesium status in Nigerians with diabetes mellitus, Ann. Clin. Biochem.26, 74–77 (1989).
G. ŞimŞek, G. Andican, E. ünal, H. Hatemi, G. Yiğit, and G. Andican, Calcium, magnesium and zinc status in experimental hyperthyroidism, Biol. Trace Element Res.57, 131–137 (1997).
L. Mosekilde, F. Meisen, J. P. Bagger, O. Myhre-Jensen, and N. S. Sorensen, Bone changes in hyperthyroidism:interrelationships between bone morphometry, thyroid function and calcium-phosphorous metabolism,Acta Endocrinol. 85, 515–525 (1977).
H. Peerenboom, E. Keck, H. L. Kruskemper, and G. Strohmeyer, The defect of intestinal calcium transport in hyperthyroidism and its response to therapy,J. Clin. Endocrinol. Metab. 59, 936–940.
P. Garnero, V. Vassy, A. Bertholin, J. P. Riou, and P. D. Delmas, Markers of bone turnover in hyperthyroidism and effects of treatment,Clin. Endocrinol. Metab. 78, 955–959 (1994).
J. E. Rizek, A. Dimich, and S. Wallach, Plasma and erythrocyte magnesium in thyroid disease, J. Clin. Endocrinol. Metab. 25, 350–358 (1965)
J. E. Jones, P. C. Desper, S. R. Shane, and E. B. Flink, Magnesium metabolism in hyperthyroidism and hypothyroidism.J. Clin. Invest. 45-49, 891 (1966).
T. Ogihara, T. Yamamoto, K. Miyai, and Y. Kumahara, Plasma renin activity and aldosterone concentration of patients with hyperthyroidism and hypothyroidism,Endocrinol. Jpn. 20, 433–443 (1973).
M. Montiel, E. Jimenez, J. A. Navaez, and M. Morell, Aldosterone and plasma renin activity in hyperthyroid rats: Effects of propranolol and propylthiouracil.J. Endocrinol. Invest. 7, 559–565 (1984).
R. Horton and E. Biglieri, Effect of aldosterone on the metabolism of magnesium,J. Clin. Endocrinol. Metab. 22, 1187–1190 (1972).
A. J. Lostroh, and M. E. Krahl, Accumulation in vitro of Mg++ and K+ in rat uterus: Ion pump activity,Bioch. Biophys. Acta 291, 260–264 (1973).
K. Darly and M. D. Granner, Thyroid hormones, inHarper’s Biochemistry, 22nd ed., Prentice-Hall, CT, Int. pp. 487–491 (1990).
M. Deluise, and J. S. Flier, Status of the red cell Na, K pump in hyper- and hypothyroidism,Metabolism 32, 25–31 (1983).
C. H. Cole, and R. W. Waddell, Alteration in intracellular sodium concentration and oubain-sensitive ATPase in erythrocytes from hyperthyroid patients,J. Clin. Endocrinol. Metab. 42, 1056 (1976).
H. Zumkley and H. Lehnert, Magnesium, Potassium and hormonal regulation,Magnesium 3, 239–243 (1984).
S. Wallach, L. N. Ci, F. H. Rogan, and H. L. Jones, Plasma and erythrocyte magnesium in health and disease,J. Lab. Clin. Med. 59, 195–210 (1962).
J. E. Jones, P. C. Desper, S. R. Shane, and E. B. Flink, Magnesium metabolism in hyperthryoidism and hypothyroidism.J. Clin. Invest. 45, 891–386 (1966).
Y. Shibutani, T. Yokota, S. Iijima, A. Fujioka, S. Katsuno, and K. Sakamoto, Plasma and erythrocyte magnesium concentrations in thyroid disease: Relation to thyroid function and the duration of illness,Jpn. J. Med. 28, 496–502 (1989).
K. Aihara, Y. Nishi, S. Hatano, M. Kihara, K. Yoshimitsu, and N. Takeichi,Am J. Clin. Nutr. 40, 26–35 (1984).
Y. Nishi, R. Kawate, and T. Usui, Zinc metabolism in thyroid disease.Postgrad. Med. J. 56, 833–837 (1980).
J. R. K. Robson and L. Spell, Erythrocyte zinc,Am J. Clin. Nutr. 34, 1983 (1981).
G. Saner, S. SavaŞan, and N. Saka, Zinc metabolism in hypothryoidism,The Lancet 340, 432–433 (1992).
K. Yoshida, Y. Kiso, T. Watanabe, K. Kaise, Y. Itagaki, M. Yamamoto, T. Sakurada, and K. Yoshinga, Erythrocyte zinc in hyperthyroidism: Reflection on integrated thryoid hormone levels over the previous few months,Metabolism 39, 182–186 (1990).
H. S. Yadav, K. K. Nagpal, B. N. Sharma, and B. N. Chaudhuri, Influence of thyroxine and temperature on zinc metabolism.Indian J. Exp. Biol. 18, 993–996 (1980).
N. Taniguchi, N. Ishikawa, T. Kondo, Inhibitory effect of thyoxine on carbonic anhydrase B isozyme biosynthesis in rabbit reticulocyte lysates.Biochem. Biophsy. Res. Commun, 85, 952–958 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ŞimŞek, G., Andican, G., Karako©, Y. et al. Calcium, magnesium, and zinc status in experimental hypothyroidism. Biol Trace Elem Res 60, 205–213 (1997). https://doi.org/10.1007/BF02784440
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784440